Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 10:56 am Sale | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 4,608,758 5.000% | -1,306,776 (-22.09%) | Filing History |
| 2022-02-09 09:07 am Sale | 2022-02-08 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,278,807 13.594% | -467,707 (-3.40%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 8,018,634 8.800% | 2,855,614 (+55.31%) | Filing History |
| 2022-01-18 06:57 am Purchase | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 6,878,377 7.510% | 6,878,377 (New Position) | Filing History |
| 2021-12-10 08:52 am Sale | 2021-12-09 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,746,514 14.059% | -2,915,302 (-17.50%) | Filing History |
| 2021-07-30 5:04 pm Sale | 2021-07-01 | 13D | 10x Genomics, Inc. TXG | Hindson Benjamin J. | 3,611,410 4.000% | -438,590 (-10.83%) | Filing History |
| 2021-07-30 5:01 pm Purchase | 2021-07-06 | 13D | 10x Genomics, Inc. TXG | Saxonov Serge | 4,851,530 5.300% | 123,879 (+2.62%) | Filing History |
| 2021-02-16 4:17 pm Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | Meritech Capital Partners V L.P. | 2,580,975 3.200% | -1,079,979 (-29.50%) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | Venrock Associates VI L.P. | 7,828,247 9.100% | -3,263,569 (-29.42%) | Filing History |
| 2021-02-16 10:34 am Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | Foresite Capital Fund I L.P. | 3,753,528 4.700% | -10,319,121 (-73.33%) | Filing History |
| 2021-02-16 09:11 am Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | SB INVESTMENT ADVISERS (UK) LTD | 0 0.000% | -3,836,232 (Position Closed) | Filing History |
| 2021-02-11 6:37 pm Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | Paladin Capital Management LLC | 2,165,199 2.700% | -6,509,968 (-75.04%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | The Vanguard Group | 6,187,705 7.720% | 6,187,705 (New Position) | Filing History |
| 2021-02-10 10:23 am Sale | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,915,534 7.400% | -877,284 (-12.91%) | Filing History |
| 2021-02-08 10:13 am Purchase | 2021-02-05 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 16,661,816 19.207% | 4,520,624 (+37.23%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,163,020 6.400% | 5,163,020 (New Position) | Filing History |